Ategra Capital Management’s Pfizer PFE Stock Holding History

Ategra Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-70,000	Closed	-$1.78M	–	29
2025 Q3	$1.78M	Hold	70,000	–	–	1.05%	19
2025 Q2	$1.7M	Buy	70,000 +10,000	+17%	+$233K	1.34%	15
2025 Q1	$1.52M	Buy	60,000 +10,000	+20%	+$262K	1.18%	17
2024 Q4	$1.33M	Buy	+50,000	New	+$1.36M	0.88%	20
2023 Q2	–	Sell	-5,593	Closed	-$228K	–	96
2023 Q1	$228K	Sell	5,593 -3,928	-41%	-$170K	0.13%	86
2022 Q4	$488K	Sell	9,521 -10,281	-52%	-$493K	0.25%	64
2022 Q3	$867K	Sell	19,802 -20,128	-50%	-$978K	0.45%	47
2022 Q2	$2.09M	Sell	39,930 -50	-0.1%	-$2.55K	1.07%	32
2022 Q1	$2.07M	Buy	39,980 +2,593	+7%	+$135K	0.91%	33
2021 Q4	$2.21M	Buy	37,387 +773	+2%	+$38.3K	0.96%	31
2021 Q3	$1.57M	Buy	+36,614	New	+$1.62M	0.75%	35

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ategra Capital Management's PFE Position: Q4 2025 in Review

Ategra Capital Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 70,000 shares — an estimated $1.78M sold.

Ategra Capital Management first reported a position in PFE in Q3 2021 and held it in 11 quarters. The position peaked at $2.21M in Q4 2021. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Ategra Capital Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Ategra Capital Management sold 70,000 Pfizer shares in Q4 2025, an estimated $1.78M.
Ategra Capital Management first reported a position in Pfizer in Q3 2021 and held it in 11 quarters.
Ategra Capital Management's Pfizer position peaked at $2.21M in Q4 2021.
2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Ategra Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.